Barclays PLC lifted its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 207.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 127,733 shares of the company's stock after purchasing an additional 86,133 shares during the period. Barclays PLC owned 0.08% of Integral Ad Science worth $1,380,000 as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in IAS. Bank of New York Mellon Corp increased its position in Integral Ad Science by 30.3% during the second quarter. Bank of New York Mellon Corp now owns 274,734 shares of the company's stock worth $2,670,000 after acquiring an additional 63,839 shares during the period. Principal Financial Group Inc. grew its position in Integral Ad Science by 9.3% in the 2nd quarter. Principal Financial Group Inc. now owns 61,108 shares of the company's stock worth $594,000 after purchasing an additional 5,189 shares during the last quarter. Versor Investments LP bought a new position in shares of Integral Ad Science during the 2nd quarter worth about $262,000. Rhumbline Advisers raised its position in shares of Integral Ad Science by 41.2% during the second quarter. Rhumbline Advisers now owns 106,697 shares of the company's stock valued at $1,037,000 after buying an additional 31,145 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Integral Ad Science by 80.8% in the second quarter. Victory Capital Management Inc. now owns 49,601 shares of the company's stock valued at $482,000 after buying an additional 22,160 shares during the period. Institutional investors and hedge funds own 95.78% of the company's stock.
Integral Ad Science Price Performance
Shares of Integral Ad Science stock traded down $0.03 during mid-day trading on Friday, reaching $10.44. 547,182 shares of the stock were exchanged, compared to its average volume of 1,327,074. The company has a market cap of $1.70 billion, a price-to-earnings ratio of 52.20, a price-to-earnings-growth ratio of 1.49 and a beta of 1.45. Integral Ad Science Holding Corp. has a fifty-two week low of $7.98 and a fifty-two week high of $17.53. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. The firm has a 50-day simple moving average of $11.11 and a 200 day simple moving average of $10.75.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The business had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. During the same period in the prior year, the company earned ($0.09) EPS. Integral Ad Science's revenue for the quarter was up 11.0% on a year-over-year basis. On average, sell-side analysts predict that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on IAS shares. Scotiabank began coverage on Integral Ad Science in a research note on Thursday, December 5th. They set a "sector perform" rating and a $10.00 price target on the stock. Benchmark restated a "hold" rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Oppenheimer reduced their target price on Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday, November 13th. Craig Hallum lowered their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating on the stock in a report on Wednesday, November 13th. Finally, Truist Financial reduced their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday, November 13th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Integral Ad Science has an average rating of "Moderate Buy" and an average price target of $15.18.
View Our Latest Stock Analysis on IAS
Insider Activity
In other news, CFO Tania Secor sold 5,240 shares of the company's stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $52,976.40. Following the transaction, the chief financial officer now directly owns 248,223 shares in the company, valued at approximately $2,509,534.53. This represents a 2.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Lisa Utzschneider sold 10,481 shares of the business's stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the completion of the transaction, the chief executive officer now owns 239,709 shares of the company's stock, valued at $2,423,457.99. This trade represents a 4.19 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 16,363 shares of company stock worth $165,629. 2.00% of the stock is owned by corporate insiders.
About Integral Ad Science
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report